Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) has announced the launch of the second phase of its INSPIRE trial evaluating the company’s lead candidate Zygel which is a transdermal cannabidiol gel that ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an obstructive sleep apnea neurostimulation therapy for patients aged 13 years and older with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback